Evidence map›Paper›PMID 23360155›Full record

ReviewInternational reviews of immunology2013

Host defense at the ocular surface.

Eric Pearlman, Yan Sun, Sanhita Roy, Mausita Karmakar, Amy G Hise, Loretta Szczotka-Flynn, Mahmoud Ghannoum, Holly R Chinnery, Paul G McMenamin, Arne Rietsch

Open access · greenAbstract readReview
In one paragraph

Review in International reviews of immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 101 citations in OpenAlex.

  1. Review
  2. Infection and immunity · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Microbiology spectrum · 2024
    Article
  8. Article
  9. A rise in the frequency ofFrontiers in cellular and infection microbiology · 2023
    Article
  10. Article
  11. Innate Immune System Activation, Inflammation and Corneal Wound Healing.International journal of molecular sciences · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Transcription Factor EepR Is Required forAntibiotics (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Eric PearlmanDepartment of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, OH 44106, USA. Eric.Pearlman@case.edu
Yan Sun
Sanhita Roy
Mausita Karmakar
Amy G Hise
Loretta Szczotka-Flynn
Mahmoud Ghannoum
Holly R Chinnery
Paul G McMenamin
Arne Rietsch
Case Western Reserve University · USCenter for Global Health · USDeakin University · AUMonash University · AU

Funding

TISSUE CULTURE AND HYBRIDOMA MODULEP30EY011373 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Irina A Pikuleva · 1997 to 2026
$17.7M
Toll Like Receptors in Bacterial KeratitisR01EY014362 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI GEORGE R DUBYAK, Eric Pearlman · 2003 to 2026
$8.7M
P. aeruginosa type III secreted effectors in corneal diseaseR01EY022052 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI RIETSCH, ARNE · 2012 to 2019
$3.1M
NEI NIH HHS P30 EY011373NEI NIH HHS P30 EY11373NEI NIH HHS R01 EY014362NEI NIH HHS R01 EY022052NEI NIH HHS R01 EY14362
6 · The paper itself

Abstract

Microbial infections of the cornea frequently cause painful, blinding and debilitating disease that is often difficult to treat and may require corneal transplantation. In addition, sterile corneal infiltrates that are associated with contact lens wear cause pain, visual impairment and photophobia. In this article, we review the role of Toll-Like Receptors (TLR) in bacterial keratitis and sterile corneal infiltrates, and describe the role of MD-2 regulation in LPS responsiveness by corneal epithelial cells. We conclude that both live bacteria and bacterial products activate Toll-Like Receptors in the cornea, which leads to chemokine production and neutrophil recruitment to the corneal stroma. While neutrophils are essential for bacterial killing, they also cause tissue damage that results in loss of corneal clarity. These disparate outcomes, therefore, represent a spectrum of disease severity based on this pathway, and further indicate that targeting the TLR pathway is a feasible approach to treating inflammation caused by live bacteria and microbial products. Further, as the P. aeruginosa type III secretion system (T3SS) also plays a critical role in disease pathogenesis by inducing neutrophil apoptosis and facilitating bacterial growth in the cornea, T3SS exotoxins are additional targets for therapy for P. aeruginosa keratitis.

Indexed as

AnimalsCell MovementContact LensesCytokinesEpithelium, CornealHumansImmunity, MucosalKeratitisLeukocidinsLipopolysaccharidesLymphocyte Antigen 96NeutrophilsPseudomonas aeruginosaPseudomonas InfectionsToll-Like ReceptorsCytokinesLeukocidinsLipopolysaccharidesLymphocyte Antigen 96Pseudomonas aeruginosa CytotoxinsToll-Like Receptors

Identifiers

PMID23360155
PMCPMC3750950
OpenAlexW2098950831

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.